Explore Baxterhealthcare.co.uk

This site is intended for Healthcare Professionals Only

Renal Care United Kingdom

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve end-stage kidney disease patient clinical outcomes and increase lifestyle flexibility.

  • Haemodialysis

    Haemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx

    Innovative Expanded Haemodialysis (HDx) therapy is the next evolution in haemodialysis treatment.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Research enabling innovative renal care and inspirational patient stories

Adverse Events Reporting

Download Resource

About Us
Baxter has been a front-runner in the treatment and management of end-stage kidney disease for over 85 years. Today, our state-of-the-art solutions for both haemodialysis  and peritoneal dialysis are transforming global renal care. It’s why you can rely on us to be the type of dedicated partner who understands the challenges you face throughout the continuum of care to meet the individual needs of your patients.

Baxter, AK 98, AN69, Artis Physio Plus, BiCart, CWP 800, Evodial, Homechoice, Nephral ST, Novaline, Polyflux, Revaclear, Sharesource, Sharesource Adequest, SoftPac, SelectBag, Theralite and Theranova are trademarks of Baxter International Inc. or its subsidiaries.

©Copyright 2025 Baxter. All rights reserved.